Annual Short Term Debt
$0.00
-$55.10 K-100.00%
31 December 2023
Summary:
Context Therapeutics annual short term debt is currently $0.00, with the most recent change of -$55.10 thousand (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$5.88 million (-100.00%). CNTX annual short term debt is now -100.00% below its all-time high of $21.84 million, reached on 31 December 2019.CNTX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$104.20 K
0.00%
01 September 2024
Summary:
Context Therapeutics quarterly short term debt is currently $104.20 thousandOver the past year, it has increased by +$104.20 thousand (+100.00%). CNTX quarterly short term debt is now -98.23% below its all-time high of $5.88 million, reached on 31 December 2020.CNTX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTX Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | +100.0% |
| 3 y3 years | -100.0% | - |
| 5 y5 years | - | - |
CNTX Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | at high | ||
| 5 y | 5 years | -100.0% | -98.2% | ||
| alltime | all time | -100.0% | -98.2% |
Context Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $104.20 K(>+9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(-100.0%) |
| June 2023 | - | $8000.00(-74.8%) |
| Mar 2023 | - | $31.70 K(-42.5%) |
| Dec 2022 | $55.10 K | $55.10 K(-29.5%) |
| Sept 2022 | - | $78.20 K(-16.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $93.10 K(+1.3%) |
| Mar 2022 | - | $91.90 K(>+9900.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(-100.0%) |
| June 2021 | - | $124.10 K(+28.7%) |
| Mar 2021 | - | $96.40 K(-98.4%) |
| Dec 2020 | $5.88 M(-73.1%) | $5.88 M |
| Dec 2019 | $21.84 M | - |
FAQ
- What is Context Therapeutics annual short term debt?
- What is the all time high annual short term debt for Context Therapeutics?
- What is Context Therapeutics annual short term debt year-on-year change?
- What is Context Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Context Therapeutics?
- What is Context Therapeutics quarterly short term debt year-on-year change?
What is Context Therapeutics annual short term debt?
The current annual short term debt of CNTX is $0.00
What is the all time high annual short term debt for Context Therapeutics?
Context Therapeutics all-time high annual short term debt is $21.84 M
What is Context Therapeutics annual short term debt year-on-year change?
Over the past year, CNTX annual short term debt has changed by -$55.10 K (-100.00%)
What is Context Therapeutics quarterly short term debt?
The current quarterly short term debt of CNTX is $104.20 K
What is the all time high quarterly short term debt for Context Therapeutics?
Context Therapeutics all-time high quarterly short term debt is $5.88 M
What is Context Therapeutics quarterly short term debt year-on-year change?
Over the past year, CNTX quarterly short term debt has changed by +$104.20 K (+100.00%)